Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Apimeds Pharmaceuticals US, Inc.

NYSE: APUS · Life Sciences · 5 alerts · CIK 1894525

Share price
$2.04Close, Nov 16
Market cap
$3.77M
Shares outstanding
1.85MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Apimeds Pharmaceuticals US, Inc. filings on SEC EDGAR ↗

9:15 AM ET 8-K
Leadership Change

Apimeds Pharmaceuticals US Leadership Change

Apimeds Pharmaceuticals US, Inc. appointed Eric Sherb as Chief Financial Officer, effective October 1, 2026, succeeding Erick Frim who resigned as Interim CFO. Mr. Sherb, a CPA with 18 years of experience, will receive an annual base salary of $60,000 under his new employment agreement. The company stated that Mr. Frim's resignation was not due to any disagreements regarding operations, policies, or practices.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.